Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth

  • Ke Zhang1, 2,
  • Ye Wang3,
  • Xiaoli Yu2,
  • Yanyan Shi2,
  • Yasai Yao2,
  • Xiaofang Wei3 and
  • Xuezhen Ma4Email author
BMC Cancer201717:899

https://doi.org/10.1186/s12885-017-3903-3

Received: 20 July 2017

Accepted: 8 December 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
20 Jul 2017 Submitted Original manuscript
23 Aug 2017 Author responded Author comments - ke Zhang
Resubmission - Version 2
23 Aug 2017 Submitted Manuscript version 2
6 Sep 2017 Reviewed Reviewer Report - Qiang Li
18 Sep 2017 Reviewed Reviewer Report - Ashok Dilly
12 Oct 2017 Reviewed Reviewer Report - Zong Sheng Guo
10 Nov 2017 Author responded Author comments - ke Zhang
Resubmission - Version 3
10 Nov 2017 Submitted Manuscript version 3
4 Dec 2017 Reviewed Reviewer Report - Zong Sheng Guo
4 Dec 2017 Reviewed Reviewer Report - Qiang Li
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
8 Dec 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3903-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Graduate School, Qingdao University, Qingdao, People’s Republic of China
(2)
Department of Oncology, Hospital of Qingdao Commercial Staff, Qingdao, People’s Republic of China
(3)
Clinical Laboratory, Qingdao Central Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, People’s Republic of China
(4)
Department of Oncology, Qingdao Central Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, People’s Republic of China

Advertisement